| Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii R López-Rojas, J Domínguez-Herrera, MJ McConnell, F Docobo-Peréz, ... Journal of Infectious Diseases 203 (4), 545-548, 2011 | 182 | 2011 |
| Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii MJ McConnell, J Domínguez-Herrera, Y Smani, R López-Rojas, ... Infection and immunity 79 (1), 518-526, 2011 | 173 | 2011 |
| Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii ME Pachón-Ibánez, F Docobo-Pérez, R López-Rojas, ... Antimicrobial agents and chemotherapy 54 (3), 1165-1172, 2010 | 158 | 2010 |
| Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance F Docobo-Pérez, GL Drusano, A Johnson, J Goodwin, S Whalley, ... Antimicrobial Agents and Chemotherapy 59 (9), 5602-5610, 2015 | 117 | 2015 |
| Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and … L López-Cerero, E Picón, C Morillo, JR Hernández, F Docobo, J Pachón, ... Clinical Microbiology and Infection 16 (2), 132-136, 2010 | 109 | 2010 |
| Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli J Machuca, A Briales, G Labrador, P Díaz-de-Alba, R López-Rojas, ... Journal of Antimicrobial Chemotherapy 69 (12), 3203-3215, 2014 | 98 | 2014 |
| Studies on the antimicrobial activity of cecropin A–melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii MJ Rodríguez-Hernández, J Saugar, F Docobo-Pérez, BG de la Torre, ... Journal of Antimicrobial Chemotherapy 58 (1), 95-100, 2006 | 73 | 2006 |
| Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam ME Pachón-Ibáñez, F Fernandez-Cuenca, F Docobo-Pérez, J Pachon, ... Journal of Antimicrobial Chemotherapy 58 (3), 689-692, 2006 | 67 | 2006 |
| Quinolone resistance reversion by targeting the SOS response E Recacha, J Machuca, P Díaz de Alba, M Ramos-Güelfo, ... MBio 8 (5), 10.1128/mbio. 00971-17, 2017 | 66 | 2017 |
| Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL … F Docobo-Pérez, L López-Cerero, R López-Rojas, P Egea, ... Antimicrobial agents and chemotherapy 57 (5), 2109-2113, 2013 | 66 | 2013 |
| Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli F Docobo-Pérez, P Nordmann, J Domínguez-Herrera, R López-Rojas, ... International journal of antimicrobial agents 39 (3), 251-254, 2012 | 66 | 2012 |
| Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells Y Smani, F Docobo-Pérez, R López-Rojas, J Domínguez-Herrera, ... Journal of Biological Chemistry 287 (32), 26901-26910, 2012 | 64 | 2012 |
| Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like F Fernández-Cuenca, Y Smani, MC Gómez-Sánchez, F Docobo-Pérez, ... International journal of antimicrobial agents 38 (6), 548-549, 2011 | 56 | 2011 |
| Effectiveness of fosfomycin for the treatment of multidrug-resistant Escherichia coli bacteremic urinary tract infections: a randomized clinical trial J Sojo-Dorado, I López-Hernández, C Rosso-Fernandez, IM Morales, ... JAMA network open 5 (1), e2137277-e2137277, 2022 | 50 | 2022 |
| Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae M Ballestero-Téllez, F Docobo-Pérez, JM Rodríguez-Martínez, ... Clinical Microbiology and Infection 23 (5), 325-331, 2017 | 50 | 2017 |
| Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus … J Domínguez-Herrera, F Docobo-Pérez, R López-Rojas, C Pichardo, ... Antimicrobial agents and chemotherapy 56 (2), 613-617, 2012 | 50 | 2012 |
| Population pharmacokinetics of teicoplanin in children V Ramos-Martín, S Paulus, S Siner, E Scott, K Padmore, P Newland, ... Antimicrobial Agents and Chemotherapy 58 (11), 6920-6927, 2014 | 49 | 2014 |
| Impact of AAC(6′)-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli J Machuca, M Ortiz, E Recacha, P Díaz-De-Alba, F Docobo-Perez, ... Journal of Antimicrobial Chemotherapy 71 (11), 3066-3071, 2016 | 48 | 2016 |
| Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates V Ramos-Martín, A Johnson, J Livermore, L McEntee, J Goodwin, ... Journal of Antimicrobial Chemotherapy 71 (4), 992-1002, 2016 | 48 | 2016 |
| Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1 JM Rodriguez-Martinez, C Pichardo, I García, ME Pachón-Ibañez, ... Clinical microbiology and infection 14 (7), 691-697, 2008 | 47 | 2008 |
Alvaro PascualProfesor de Microbiologia. Universidad de Sevilla在 us.es 的电子邮件经过验证
